Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
about
Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital settingPro/con debate: are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?Insights into temporal patterns of hospital patient safety from routinely collected electronic dataManagement practices and major infections after cardiac surgery.Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?Decreasing healthcare-associated infections (HAI) is an efficient method to decrease healthcare-associated Methicillin-resistant S.aureus (MRSA) infections Antimicrobial resistance data from the German national nosocomial surveillance system KISS.Use of longitudinal surveillance data to assess the effectiveness of infection control in critical care.To screen or not to screen for methicillin-resistant Staphylococcus aureus.Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detectionPrevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.Guidelines for the prevention of intravascular catheter-related infections.Chemical Composition, Modulatory Bacterial Resistance and Antimicrobial Activity of Essential Oil the Hyptis martiusii Benth by Direct and Gaseous Contact.Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremiaMethicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Central line bundle implementation in US intensive care units and impact on bloodstream infectionsTemporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based studyA research framework for reducing preventable patient harmExcess mortality and long-term disability from healthcare-associated staphylococcus aureus infections: a population-based matched cohort studyVancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals.Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001-2010.The usefulness of arbekacin compared to vancomycin.Infection prevention practices in neonatal intensive care units reporting to the national healthcare safety network.Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United StatesCharacterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.TD-1792 versus vancomycin for treatment of complicated skin and skin structure infectionsIncidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt.Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout MutantsGenotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistancePrevalence of qacA/B Genes and Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates in the Setting of Chlorhexidine Bathing Without Mupirocin.Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus.Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection.Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta.
P2860
Q24186422-B3EC63BB-148E-4580-A33F-E3DA3F6BA105Q26863657-D55F102C-662B-400A-8CD1-07C24261673CQ28650512-86A8AA7A-0729-4156-9320-B6309E94D2C7Q30371753-FC6802A4-6E56-420F-8795-D7E7E8BE25DFQ30424717-434FBF7F-43BC-42C9-8CCF-4A3C10B4C4A5Q30563367-D343FEA9-6E2B-4DA8-9CB8-E935B78E35A4Q33508663-04925A13-7F90-4207-A099-6C014A13598FQ33523664-97E560EF-1C39-4148-BB76-872606A666F2Q34031327-72CB340B-AC52-4949-9327-0287BEE16F9CQ34057519-E3E0662C-CF3D-41FC-9728-A04610D31653Q34175393-E619F6EF-F08B-4B70-A4F0-3166F0B6F6E4Q34192782-3037CA23-0B26-4718-B40C-447CD9BD2290Q34288755-83CC9335-06C4-40E9-B17E-98FD03040CBAQ34407240-6403ABB7-5F82-4C7B-AACC-4294B2D56427Q34478074-189BA4DD-DCB4-4676-A808-B63C6961C8C2Q34498641-AF8CB38A-9935-4A3E-8EE0-979B2D204670Q34632977-5AA942B9-0A5E-4795-941F-BFD69F7287E7Q34699187-76F2DF35-21F1-4969-9687-FBE5B91393B6Q34936692-48ADB31B-58D8-4987-8F78-062DF994C74BQ35004943-84F412FD-5AF8-43E9-8649-42E6D9C358CCQ35105932-537FD845-50D8-4451-BB2E-2FE06F480250Q35193427-22D6B9F4-8EC1-4F56-98F3-9D9169C255B6Q35534273-D095A8EB-4002-4A43-BF37-0D653357E0CEQ35689372-DD7FF1F7-CA7B-4BB0-8640-4B9ADD231DC3Q35736907-F28982E8-F460-4602-B1B0-0A5BD39145BDQ35980009-DD64B980-6772-4BFE-B1FA-FC53D316145CQ35999171-39D810DA-89E3-4DA5-AA4B-824C6FB3327CQ36247662-C9A692E7-A3C0-4EE3-9F70-E893C6CCFDAEQ36304320-E0ADB963-1786-4327-8D60-E0F91136E00DQ36363012-D4F68C38-46B8-47C5-8BCB-488BE765AA26Q36364048-17EAE1F5-6E92-47B9-B209-93A68D364D91Q36419983-D79BD7BA-B372-408B-A01E-60FF3BD48930Q36434414-540115AA-E26A-477B-9152-37BA88A06BBFQ36489501-2AA45E4B-0300-4E86-B298-56D680D5DBF2Q36736262-3FEEEEA8-B95D-4969-9BFE-266D2B2B9862Q36757737-B565772D-40FB-41B5-8CAE-FC10F3F6E03DQ36803602-A89A49BF-98DD-42BC-BD09-9DFA2E61C36DQ36853965-66748D5D-311F-4E52-A8E3-5BA89FAC24C9Q36903232-C6BFDDA9-D094-4D2F-A252-9EE331DF997FQ36916829-E664B27E-E9C3-4DE7-9EA0-C5D8487022A2
P2860
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@ast
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@en
type
label
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@ast
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@en
prefLabel
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@ast
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@en
P2093
P356
P1476
Methicillin-resistant Staphylo ...... tensive care units, 1997-2007.
@en
P2093
Deron C Burton
John A Jernigan
Jonathan R Edwards
Scott K Fridkin
Teresa C Horan
P304
P356
10.1001/JAMA.2009.153
P407
P577
2009-02-01T00:00:00Z